You are here

  • Home
  • Archive
  • Volume 19, Issue 9
  • Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20191000
Apr 20191300
May 20191800
Jun 20191200
Jul 20191800
Aug 20192200
Sep 20191000
Oct 2019400
Nov 2019700
Dec 2019700
Jan 20202100
Feb 2020600
Mar 20201101
Apr 2020800
May 20201200
Jun 20201200
Jul 20201300
Aug 2020400
Sep 2020800
Oct 20201200
Dec 20201000
Jan 20211400
Feb 20211001
Mar 20211200
Apr 2021400
May 2021100
Jun 2021001
Sep 2021100
Oct 20211200
Nov 20212401
Dec 20211400
Jan 20221601
Feb 2022801
Mar 20221400
Apr 20221000
May 20223401
Jun 20224000
Jul 20222900
Aug 20225702
Sep 20223400
Oct 20223400
Nov 20221600
Dec 20221801
Jan 20231000
Feb 20238200
Mar 2023600
May 2023401
Jun 2023600
Jul 2023200
Aug 20231100
Sep 20231201
Oct 2023600
Nov 20231400
Dec 20235400
Jan 2024400
Feb 2024600
Mar 2024800
Apr 20241200
Total877012